Versant Venture Management
Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GLUE, IPSC, LENZ, JBIO, CTNM, and represent 93.81% of Versant Venture Management's stock portfolio.
- Added to shares of these 1 stock: IPSC (+$28M).
- Started 1 new stock position in IPSC.
- Reduced shares in these 1 stock: GLUE (-$20M).
- Versant Venture Management was a net buyer of stock by $7.7M.
- Versant Venture Management has $141M in assets under management (AUM), dropping by -6.39%.
- Central Index Key (CIK): 0001560009
Tip: Access up to 7 years of quarterly data
Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 37.0 | $52M | -27% | 3.2M | 16.45 |
|
| Century Therapeutics Common Stock (IPSC) | 19.4 | $28M | NEW | 12M | 2.26 |
|
| Lenz Therapeutics Common Stock (LENZ) | 17.2 | $24M | 2.7M | 9.15 |
|
|
| Jade Biosciences Common Stock (JBIO) | 15.2 | $21M | 1.5M | 14.05 |
|
|
| Contineum Therapeutics Common Stock (CTNM) | 5.0 | $7.1M | 543k | 13.06 |
|
|
| CRISPR Therapeutics Common Shares (CRSP) | 5.0 | $7.1M | 149k | 47.57 |
|
|
| Skye Bioscience Common Stock (SKYE) | 0.9 | $1.2M | 2.0M | 0.61 |
|
|
| Tempest Therapeutics Common Stock | 0.3 | $442k | 270k | 1.64 |
|
Past Filings by Versant Venture Management
SEC 13F filings are viewable for Versant Venture Management going back to 2014
- Versant Venture Management 2026 Q1 filed May 5, 2026
- Versant Venture Management 2025 Q4 filed Feb. 12, 2026
- Versant Venture Management 2025 Q3 filed Nov. 10, 2025
- Versant Venture Management 2025 Q2 filed Aug. 11, 2025
- Versant Venture Management 2025 Q1 filed May 7, 2025
- Versant Venture Management 2024 Q4 filed Feb. 12, 2025
- Versant Venture Management 2024 Q3 filed Nov. 8, 2024
- Versant Venture Management 2024 Q2 filed Aug. 7, 2024
- Versant Venture Management 2024 Q1 filed May 3, 2024
- Versant Venture Management 2023 Q4 filed Feb. 8, 2024
- Versant Venture Management 2023 Q3 filed Nov. 3, 2023
- Versant Venture Management 2023 Q2 filed Aug. 9, 2023
- Versant Venture Management 2023 Q1 filed May 11, 2023
- Versant Venture Management 2022 Q4 filed Feb. 9, 2023
- Versant Venture Management 2022 Q3 filed Nov. 10, 2022
- Versant Venture Management 2022 Q2 filed Aug. 11, 2022